These 6 High-Yield Dividends May Be Too Good to Be True

Six high-yield stocks—Altria, Pfizer, Western Union, Franklin Resources, LyondellBasell and BXP—show dividend-coverage risks despite none announcing an additional cut. Pfizer's $1.72 annual dividend exceeds its $0.77 trailing EPS, Western Union missed Q2 EPS consensus by $0.11 while margin fell 400bps to 15%, and LyondellBasell reported a $738M FY2025 net loss as operating cash flow declined to $2.26B from $4.94B in 2023. BXP has already cut its quarterly dividend 29% to $0.70, while strained cash flow, office-sector headwinds and elevated liabilities leave its revised payout subject to continued scrutiny.

Analysis

The highest-probability repricing risk is WU, where declining transaction economics create a self-reinforcing capital-allocation problem: preserving the dividend consumes cash that could otherwise fund digital-product investment or debt reduction, worsening its competitive position against Remitly (RELY), Wise (WISE.L) and fintech rails. A cut is not necessarily imminent given current cash coverage, but another margin or revenue-guide reset in the next 1-3 quarters would force the market to value WU as an ex-growth runoff asset rather than a yield vehicle. The paused repurchase program removes the natural buyer that has historically cushioned downside.

LYB's risk is more cyclical than purely dividend-driven. Any distribution reduction would likely be interpreted as prudent balance-sheet defense, but it would also confirm that the earnings trough is lasting longer than the market expects and could pressure the multiple toward distressed European-chemical peers. The more important 6-18 month variable is whether global polyethylene capacity rationalization and Chinese export behavior improve; a supply disruption is not a durable replacement for an underlying volume and spread recovery.

The article's broad dividend-warning framing is too indiscriminate for MO, PFE and BEN. Negative equity at MO is substantially a legacy capital-return accounting outcome, while a single quarterly operating-cash-flow datapoint is not a reliable dividend measure for a highly cash-generative tobacco franchise. PFE's payout is better judged against post-separation operating cash flow, patent-cliff replacement revenue and deleveraging capacity; absent a downward revision to those metrics, its yield alone is unlikely to trigger a near-term cut. BXP remains the clearest structural coverage watch, but the relevant catalyst is leasing spreads and refinancing cost—not GAAP earnings or raw operating cash flow.

Key Decisions for Investors

• Initiate a 3-6 month WU short only on a break below the post-earnings low or after another EBITDA-margin guide-down; target 15-20% downside as the valuation resets to runoff economics, with a stop on evidence that Beyond Efficiency savings restore margins above 18%. Avoid shorting solely for dividend-cut risk while free cash flow still covers the payout.
• Express LYB downside through a 6-9 month LYB put spread, preferably after any supply-shock-driven rally. The thesis is a normalization of temporary supply support before a broad chemical-cycle recovery; exit if management guides to sustained improvement in North American ethylene/polyolefin spreads or net debt declines materially without further capital-return pressure.
• Maintain BXP as an underweight/short candidate versus a diversified REIT benchmark such as VNQ over the next 6-12 months. The trade is falsified by sustained positive leasing spreads, improved occupancy, and debt refinancing executed near current assumptions; a further dividend cut is a catalyst, not the primary thesis.
• Do not short MO, PFE, or BEN on the cited coverage signals alone. Set earnings alerts: MO nicotine-pouch share stabilization and combustible pricing realization; PFE 2027-2028 revenue replacement and net-debt trajectory; BEN organic long-term flows and operating-cash-flow normalization. A dividend thesis becomes actionable only if these operating indicators deteriorate alongside explicit capital-return guidance.